Pfizer terminates $160bn merger with Allergan
The decision comes two days after the US Treasury announced additional action to curb inversions, and address earnings stripping. The US Department of the Treasury and the Internal
The decision comes two days after the US Treasury announced additional action to curb inversions, and address earnings stripping. The US Department of the Treasury and the Internal
Sareum plans to start clinical trials in second quarter of this year, subject to final NHS approval. The company plans to carry out two phase I clinical trials
Inflectra is indicated to treat patients with various severe autoimmune diseases such as Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis. The FDA
Accelerated review status enables CHMP to grant an opinion two months earlier than the standard 210-day period. In XBiotech’s case, a decision may happen as early as third
The study, which is anticipated to commence by the middle of this year, will see IXICO support the use of novel brain scanning techniques in a phase I/II
Nimbus will get $400m up front and up to $800m if certain development milestones are reached. The Nimbus Apollo program includes lead candidate NDI-010976 and other preclinical ACC
DSG will deliver a fully supported eCaseLink EDC system, including IWRS Web-based randomization-clinical supply, a central lab and third-party CRO data integration, and data management services. The move
The drug, dupilumab, improved rash, itching and other symptoms of AD, which is a severe form of eczema. The SOLO1 and SOLO2 studies met their primary endpoints in
Stremvelis is a stem cell gene therapy created from the patient’s own cells. It was designated as an orphan medicinal product in August 2005. It was originally developed
A team from Purdue University and the National Institutes of Health used cryo-electron microscropy to create the picture of a mature Zika virus particle. The process included freezing